Brun-Vézinet F - Search Results

1

Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.

Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D; ANRS CO 05 HIV-2 Cohort. Visseaux B, et al. J Infect Dis. 2012 Jan 1;205(1):111-20. doi: 10.1093/infdis/jir698. Epub 2011 Dec 2. J Infect Dis. 2012. PMID: 22140264

2

Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Plantier JC, Vergne L, Damond F, MBoup S, MPoudi-NGole E, Buzelay L, Farfara I, Brand D, Peeters M, Brun-Vézinet F, Delaporte E, Barin F. Plantier JC, et al. J Clin Microbiol. 2002 Mar;40(3):1010-22. doi: 10.1128/JCM.40.3.1010-1022.2002. J Clin Microbiol. 2002. PMID: 11880431 Free PMC article.

3

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vézinet F, Clavel F, Girard PM; Narval Trial Group. Meynard JL, et al. AIDS. 2002 Mar 29;16(5):727-36. doi: 10.1097/00002030-200203290-00008. AIDS. 2002. PMID: 11964529 Clinical Trial.

4

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, Chène G, Matheron S, Campa P, Brun-Vézinet F, Simon F. Damond F, et al. J Clin Microbiol. 2002 Oct;40(10):3654-9. doi: 10.1128/JCM.40.10.3654-3659.2002. J Clin Microbiol. 2002. PMID: 12354861 Free PMC article.

5

Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.

Masquelier B, Peytavin G, Leport C, Droz C, Duran S, Verdon R, Besnier JM, Chêne G, Raffi F, Brun-Vézinet F; APROCO Study Group. Masquelier B, et al. J Infect Dis. 2002 Nov 15;186(10):1503-7. doi: 10.1086/344358. Epub 2002 Oct 23. J Infect Dis. 2002. PMID: 12404170

6

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.

Descamps D, Flandre P, Joly V, Meiffrédy V, Peytavin G, Izopet J, Tamalet C, Zeng AF, Harel M, Lastère S, Aboulker JP, Yéni P, Brun-Vézinet F; NOVAVIR (ANRS 073) Study Group. Descamps D, et al. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):464-71. doi: 10.1097/00126334-200212150-00002. J Acquir Immune Defic Syndr. 2002. PMID: 12473833 Clinical Trial.

7

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

8

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.

Matheron S, Descamps D, Boué F, Livrozet JM, Lafeuillade A, Aquilina C, Troisvallets D, Goetschel A, Brun-Vezinet F, Mamet JP, Thiaux C; CNA3007 Study Group. Matheron S, et al. Antivir Ther. 2003 Apr;8(2):163-71. Antivir Ther. 2003. PMID: 12741629 Clinical Trial.

9

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Ravela J, Betts BJ, Brun-Vézinet F, Vandamme AM, Descamps D, van Laethem K, Smith K, Schapiro JM, Winslow DL, Reid C, Shafer RW. Ravela J, et al. J Acquir Immune Defic Syndr. 2003 May 1;33(1):8-14. doi: 10.1097/00126334-200305010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12792349 Free PMC article.

10

Clinically relevant interpretation of genotype for resistance to abacavir.

Brun-Vézinet F, Descamps D, Ruffault A, Masquelier B, Calvez V, Peytavin G, Telles F, Morand-Joubert L, Meynard JL, Vray M, Costagliola D; Narval (ANRS 088) Study group. Brun-Vézinet F, et al. AIDS. 2003 Aug 15;17(12):1795-802. doi: 10.1097/00002030-200308150-00008. AIDS. 2003. PMID: 12891065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page